About BioCision
BioCision is a company based in Larkspur (United States) founded in 2007. BioCision has raised $11.1 million across 4 funding rounds from investors including Brooks Automation, CYWP Fund and Research Corporation Technologies. The company has 48 employees as of December 31, 2022. BioCision operates in a competitive market with competitors including Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.
- Headquarter Larkspur, United States
- Employees 48 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Biocision Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.1 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Brooks Automation
& 2 more
-
Employee Count
48
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of BioCision
Unlock access to complete
Unlock access to complete
Software Development Team
50 people
Sales and Marketing
39 people
Leadership Team
24 people
Senior Team
19 people
Account Team
17 people
Finance and Accounting
16 people
Legal and Compliance
9 people
Human Resources and Administration
9 people
Unlock access to complete
Funding Insights of BioCision
BioCision has successfully raised a total of $11.1M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(01 Jul 2013)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2016 | Amount | Series A - BioCision | Valuation | CYwP Funds |
|
| Jan, 2015 | Amount | Series A - BioCision | Valuation |
investors |
|
| Mar, 2014 | Amount | Series A - BioCision | Valuation |
investors |
|
Investors in BioCision
BioCision has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Brooks Automation, CYWP Fund and Research Corporation Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Flexible growth capital is provided by CYWP Fund.
|
Founded Year | Domain | Location | |
|
Research Corporation Technologies is engaged in licensing biomedical technologies.
|
Founded Year | Domain | Location | |
|
Vacuum robots for semiconductor wafer handling are developed.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioCision
Financial Statements - BioCision
Biocision Comparisons
Competitors of BioCision
BioCision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brooks Automation, Bridge to Life, Hemanext, Atelerix and Cellbox Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vacuum robots for semiconductor wafer handling are developed.
|
|
| domain | founded_year | HQ Location |
Cold storage solutions for organ transplant preservation are provided.
|
|
| domain | founded_year | HQ Location |
Technologies for blood and product storage are developed.
|
|
| domain | founded_year | HQ Location |
Technology for cell storage and transportation is developed.
|
|
| domain | founded_year | HQ Location |
Portable devices for cell storage and transport are provided.
|
|
| domain | founded_year | HQ Location |
Thermal packaging solutions and cold chain monitoring services are provided.
|
Latest news on Biocision
Frequently Asked Questions about BioCision
BioCision was founded in 2007 and raised its 1st funding round 6 years after it was founded.
BioCision is headquartered in Larkspur, United States. It is registered at Larkspur, Colorado, United States.
BioCision is a funded company, having raised a total of $11.1M across 4 funding rounds to date. The company's 1st funding round was a Series A of $5.85M, raised on Jul 01, 2013.
As of Dec 31, 2022, the latest employee count at BioCision is 48.
BioCision develops and supplies cell cryopreservation products, systems, and solutions. Products include CoolCell Freezing Containers, ThawSTAR Automated Cell Thawing Systems, BioT Temperature Stability Systems, CoolRack Tube Cooling Modules, CoolSink Plate Cooling Modules, ThermalTray Cooling Platforms, TruCool Hinged CryoBoxes, TruCool Leak-Proof Cryogenic Vials and TruCool Lab Accessories. Its products are used by institutions in the biotech, pharmaceutical, clinical, diagnostic, academic and government scientific community.
BioCision's top competitors include Brooks Automation, Hemanext and Bridge to Life.
BioCision has 3 investors. Key investors include Brooks Automation, CYWP Fund, and Research Corporation Technologies.